Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17072)	12/20/1998 3:15:00 PM
From: alan laValley	Read Replies (1) \| Respond to of 23519

Vlad; I see this situation as you do. While it is well documented the numerous errors that Wilson & Co. have made, there is a window of opportunity to regain credibility. If however, a domestic partner is not signed, it will NOT mean the demise of Vivus, but cause the stock to linger in the $3 range for near term . One must remember soon there will $25 million in cash and new global opportunities. Personally I will hold off final judgement and my buy/sell/hold position until after earnings and conference call. Would anyone like to comment on the terms a domestic partner would have to agree to? Lets assume today with 4,000 scripts per/wk @ $100 per/skript= $20+ million annually. I would assume an substantial up front payment is part of the negotiations. It would be reasonable to expect one years gross sales as part of deal. If in fact that happens, $45 million in cash and maybe some share buyback program. Al

To: VLAD who wrote (17072)	12/20/1998 5:57:00 PM
From: AlienTech	Respond to of 23519

>>If he has nothing productive to offer us then he better have a lot of explaining to do << Enough talk, Just get a rope!